201 related articles for article (PubMed ID: 33061470)
1. Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant
Zhang P; Wang J; Hu H; Zhang S; Wei J; Yang Q; Qu T
Infect Drug Resist; 2020; 13():3233-3242. PubMed ID: 33061470
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
[TBL] [Abstract][Full Text] [Related]
4. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
[TBL] [Abstract][Full Text] [Related]
5. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H
J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
Chen Y; Chen Y; Liu P; Guo P; Wu Z; Peng Y; Deng J; Kong Y; Cui Y; Liao K; Huang B
BMC Geriatr; 2022 Jul; 22(1):573. PubMed ID: 35831805
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for a Hospital-Acquired Carbapenem-Resistant
Cao Z; Yue C; Kong Q; Liu Y; Li J
Infect Drug Resist; 2022; 15():641-654. PubMed ID: 35241916
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant
Zheng X; Wang JF; Xu WL; Xu J; Hu J
Antimicrob Resist Infect Control; 2017; 6():102. PubMed ID: 29026535
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant
Meng H; Han L; Niu M; Xu L; Xu M; An Q; Lu J
Infect Drug Resist; 2022; 15():4241-4251. PubMed ID: 35959146
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019.
Li M; Yang S; Yao H; Liu Y; Du M
Infect Dis Ther; 2023 Feb; 12(2):473-485. PubMed ID: 36520329
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study.
Meng H; Yang J; Niu M; Zhu H; Zhou Y; Lu J
Int J Antimicrob Agents; 2023 Oct; 62(4):106933. PubMed ID: 37500022
[TBL] [Abstract][Full Text] [Related]
15. A Novel Nomogram for Predicting Risk Factors and Outcomes in Bloodstream Infections Caused by
Chen Y; Ying S; Jiang L; Dong S; Dai J; Jin X; Yu W; Qiu Y
Infect Drug Resist; 2022; 15():1317-1328. PubMed ID: 35378894
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort.
de Souza ILA; Cappellano P; Ferreira DB; Bergamasco MD; das Chagas Neto TC; Kerbauy FR; Baiocchi OCG; Pignatari ACC
PLoS One; 2024; 19(1):e0297161. PubMed ID: 38277372
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of
Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant
Liu KS; Tong YS; Lee MT; Lin HY; Lu MC
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34209780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
